Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACTA.L Regulatory News (ACTA)

  • There is currently no data for ACTA

Development Contract

25 Nov 2009 07:00

RNS Number : 9866C
Acta S.p.A.
25 November 2009
 



25 November 2009  

Acta S.p.A. ("Acta" or the "Company")

Development Contract 

Acta, the clean-tech catalysts and products companyis pleased to announce the award of a development contract from DuPont, the Fortune 500 science-based products and services company, with collaboration from a number of eminent US universities  

The contract is worth $280,000 to Acta over its initial twelve month period, and, subject to satisfactory performance in the first year, is expected to be extended to a second year.

The contract is part of the US Department of Defense ("DoD") project won by DuPont for the development of a Next Generation Man Wearable Power System, which aims to develop a small, lightweight, efficient and low cost wearable fuel cell system to power the US infantry's electronic battlefield equipment. The system will be based on alkaline membrane fuel cell technology and non-platinum catalysts, in order to achieve the technical and commercial criteria specified by the DoD. 

Paolo Bert, Chief Executive, Acta, commented: 

"We are delighted to be entering this important development contract with DuPont, the makers of the industry standard NafionTM membrane.

Since the formation of Acta we have been promoting the cost and performance benefits of fuel cell systems based on alkaline membranes. It is strategic to the fuel cell industry that membrane technologies should be developed further, and we are delighted to be pursuing this avenue together with DuPont, one of the world's leaders in membrane developments."

John Colven, Global Venture Manager, DuPont Fuel Cells, said:

"This fuel cell technology will enable a leap forward in the current state-of-the-art in small power systems. It goes without saying that we're looking at the next generation of fuel cell technology. Each of our partners brings unique capabilities to this long-range project, so it is very exciting."

About the Project:

Alkaline membrane fuel cells have the potential to overcome the simplification, performance and cost barriers associated with acidic-based PEM fuel cells by simplifying the water management requirements, enabling increased oxygen reduction kinetics, and eliminating the need for expensive platinum. 

The project aim is to miniaturise the fuel cell technology, utilising non-precious metal catalysts and a solid polymer membrane in an alkaline environment. Acta's role in the first year of the project will be to develop membrane electrode assemblies (MEA's) based on the new membranes and ionomers developed by the project partners, to incorporate the best performing non-platinum catalysts, and to carry out fuel cell performance testing and evaluation on the MEA's. The US Army project is led by DuPont along with Acta and other participants include Georgia Institute of Technology, North Carolina State University, Northeastern University, and Virginia Polytechnic Institute.

- Ends -

For further information please contact:

Acta S.p.A:

Paul Barritt, Chief Financial Officer

Tel: +39 050 644281

Charles Stanley Securities (Nominated Adviser):

Tel: +44 (0) 20 7149 6000

Russell Cook / Freddy Crossley 

Notes to Editors

About Acta 

Acta develops and manufactures clean technology products and unique patented catalysts which have been launched to the renewable energy, automotive, battery and industrial markets. Acta is also developing other commercial opportunities using its catalysts for industrial waste treatment.

Acta's catalysts and alkaline system know-how are at the heart of the Company's development of a new, high pressure water electrolyser technology which has demonstrated low cost, platinum free, high pressure hydrogen generation. Combined with a platinum free fuel cell, the system offers a solution to the problem of how to store surplus energy produced from large scale, intermittent renewable energy sources (eg wind farms). In addition, the low cost, small size and simplicity of the hydrogen generator makes it ideally suited as a recharger of commercial fuel cell applications (fuel cell bikes, electrical generators, UPS systems, etc).

Acta's catalysts are also undergoing customer tests in applications such as ammonia treatment (removal of ammonia from an industrial waste stream), and zinc-air batteries (a high performance and environmentally friendly battery technology), as well as fuel cell and other applications.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUSRARKVRAUAA
Date   Source Headline
22nd Sep 20107:00 amRNSInterim Results
4th Aug 20107:01 amRNS2.7 MW Photovoltaic Project Consents Received
20th Jul 20107:01 amRNSService Station Agreement
20th Jul 20107:00 amRNSChange of Adviser
13th Jul 20105:19 pmRNSTR-1: Notification of Major Interest in Shares
13th Jul 20107:00 amRNSPositive Response to New Italian Feed-in-Tariff
1st Jul 20105:53 pmRNSIssue of Equity
1st Jul 201012:16 pmRNSActa exhibits at Goodwood Festival of Speed
29th Jun 20107:00 amRNSResult of AGM & marketing update
10th Jun 201010:52 amRNSActa unveils world's first hydrogen-powered tender
9th Jun 20108:00 amRNSChange of web site address
2nd Jun 20107:15 amRNSAnnual Financial Report
2nd Jun 20107:00 amRNSRe Contract
28th Apr 20107:00 amRNSAward of grant
22nd Apr 20107:00 amRNSHydrogen fuel enrichment test results
26th Mar 20105:05 pmRNSDirector/PDMR Shareholding
25th Mar 20107:00 amRNSPreliminary Results
23rd Mar 20107:00 amRNSPhotovoltaics Programme
3rd Mar 20107:00 amRNSSumitomo Corporation Distribution Agreement
15th Feb 20107:00 amRNSHydrogen Generator wins Qualitec Technology Award
2nd Feb 20107:00 amRNSTrading Update
20th Jan 20107:00 amRNSDirector/PDMR Shareholding
10th Dec 20098:50 amRNSTrade Show & Product Launch Update
25th Nov 20097:00 amRNSDevelopment Contract
22nd Oct 20097:00 amRNSProduct Launch Confirmation
24th Sep 20097:00 amRNSHalf Yearly Report
23rd Sep 20099:55 amRNSNotice of Forthcoming Interim Results Statement
10th Aug 20097:00 amRNSProduct Launch Update
22nd Jul 200912:08 pmRNSStatement re price movement
17th Jul 20097:00 amRNSTrading Update
25th Jun 20095:16 pmRNSResult of AGM
1st Jun 20097:00 amRNSPosting of Annual Report
28th May 20097:00 amRNSGrant of Options
26th Mar 20097:00 amRNSFinal Results
29th Jan 200910:39 amRNSDirectorate Change
26th Jan 20097:00 amRNSGrant Approval
22nd Jan 20097:00 amRNSTrading Statement
21st Jan 20092:06 pmRNSDirector Declaration
19th Jan 20097:00 amRNSChange of Adviser
7th Nov 20087:00 amRNSRe Contract
13th Oct 20081:11 pmRNSDirector/PDMR Shareholding
1st Oct 20087:00 amRNSDirector/PDMR Shareholding
24th Sep 20087:00 amRNSInterim Results
5th Sep 20084:47 pmRNSTrading Update
3rd Sep 20087:00 amRNSNotice of Results
23rd Jul 20087:00 amRNSCatalyst Launch Programme
17th Jul 20087:00 amRNSTrading Statement
23rd Jun 20087:00 amRNSDirectorate Change
10th Jun 20087:00 amRNSAGM Statement
30th Apr 20087:00 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.